The timeline below represents averages across the study population
Novel Dual GLP-1/GIP Receptor Agonists Show Neuroprotective Effects in Alzheimers and Parkinsons Disease Models
Retatrutide is the International Nonproprietary Name (INN) assigned by the WHO, and LY3437943 is the development code used by Eli Lilly in clinical trials and scientific publications
Whether you want to reduce oxidative stress, boost immune function, or promote overall wellness, our team provides personalized care tailored to your individual health goals
it smells great
Depending on your individual situation, your healthcare provider may recommend slowing dose escalation, temporarily remaining on the current dose, reviewing your eating habits, evaluating other medications, or discussing alternative physician-guided weight-loss options